Here at Tapemark, we are the foremost leaders and innovators for development and manufacturing in transdermal and oral thin film drug delivery. No, really, we are. We offer a fully-integrated solution. Our services include formulation, optimization, blending, coating, converting, primary packaging, secondary cartoning, and kitting to commercially manufacture transdermal and oral thin film drugs. We have successful experience with NDA, ANDA, and 505(b)2 FDA approvals including those for Schedule I controlled substances. As a team of subject matter experts and craftsmen, we nurture our client's pharmaceutical formulation, develop it, scale it, and guide it through the FDA approval process. Tapemark is comprised of pioneering chemists, researchers, and engineers. As world experts in transdermal and oral thin film drug delivery, we offer full project management services to keep projects ahead of milestones and never behind. Tapemark has significant experience launching NDA and ANDA drugs to offer our clients the most hands-on and successful partnership in the CDMO space. Tapemark is known for its superior, truly unmatched, state-of-the-art equipment. Since the beginning, our investment has been laser-focused on owning and operating a 150,000-square-foot facility that cannot be beat in the industry. We are devoted to the industry's brightest people and most advanced equipment. We know what works. We know what doesn't. And we know where we can innovate and deliver for efficient FDA approvals and progressive timelines. The Tapemark team is powered, staffed, and driven to help clients move faster, better, and with unrivaled quality to benefit the patient and improve compliance. Our pharmaceutical products perform in the clinic and surpass FDA standards. Tapemark is privately-held and based in West St. Paul, Minnesota, with multiple facilities in a campus environment. The company services the pharmaceutical, medical, and consumer products markets.
View Top Employees from TapemarkWebsite | http://www.tapemark.com |
Revenue | $25 million |
Funding | $2 million |
Employees | 73 (73 on RocketReach) |
Founded | 1952 |
Address | 1685 Marthaler Ln, Saint Paul, Minnesota 55118, US |
Phone | (651) 455-1611 |
Fax | (651) 450-8403 |
Technologies |
JavaScript,
HTML,
Twitter
+26 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Pharmaceuticals, Staffing Agency, Transdermal Drug Delivery, Healthcare, Administrative Services, Oral/Transmucosal Soluble Film, Transportation, Snap and Snapplicator single-dose packaging, Topical pads and patches, CDMO, Blending/Mixing, Coating, Converting, Schedule II-V Manufacturer of Controlled Substances, Cgmp |
Web Rank | 14 Million |
Keywords | Tapemark Careers, Tapemark |
Competitors | Bennett Packaging of Kansas City, DELPHARM GAILLARD, Jones Packaging Inc., Taipak Enterprises Ltd., Ukrplastic |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies |
Looking for a particular Tapemark employee's phone or email?
The Tapemark annual revenue was $25 million in 2024.
Cormac Lyons is the Vice President, Research and Development of Tapemark.
73 people are employed at Tapemark.
Tapemark is based in Saint Paul, Minnesota.
The NAICS codes for Tapemark are [325, 32541, 3254, 32].
The SIC codes for Tapemark are [28, 283].